HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.
Clinical fit
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
FDA source Exact FDA submission Checked 2026-09-05
Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.
FDA source Exact FDA submission Checked 2026-09-05
Adult acquisition aid requiring trained users and qualified interpretation. Clinical-study image quality varied by view, particularly subcostal IVC. PCCP allows specified compatibility changes after validation; it does not establish that every current probe/OS was tested in the initial v1.1.1 study.
FDA source Exact FDA submission Checked 2026-09-05
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
FDA submission
K242807
FDA source Exact FDA submission Checked 2026-08-31
The FDA summary describes an offline application with medical data stored locally on the tablet and no data transfer to a DESKi-controlled server for its functions.
FDA source Exact FDA submission Checked 2026-09-05
Corrects the baseline's nonspecific Hybrid label using the exact summary; current device configuration remains separately scoped.
Vendor confirmation Exact FDA submission Checked 2026-09-05
FDA-local data flow is documented, but FAQ/pricing security language does not supply a dated scoped attestation or a complete installed security-control assessment.
Training and support
Users require ultrasound-basics and HeartFocus training provided by DESKi or a trained medical professional using approved training material.
FDA source Exact FDA submission Checked 2026-09-05
Exact local competency sign-off, onboarding duration and contractual support remain site/vendor matters.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.
Evidence summary
The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.
FDA source Exact FDA submission Checked 2026-09-05
Reviewed sources checked Exact FDA submission Checked 2026-09-05
A single disease-detection sensitivity is not established by the reviewed acquisition-quality studies.
Reported specificity
93.9%
FDA source Exact FDA submission Checked 2026-08-13
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
Proportion of clips saved with Best-Effort Record judged of diagnostic image quality in the prospective acquisition study in 240 adults aged at least 22 at one French and one US center; eight nurse operators, five blinded cardiologist assessors; recorded clips graded using ACEP scale.
Tested version: HeartFocus v1.1.1 with Clarius in K242807 clinical study
Manufacturer prospective multicenter paired acquisition study; trained novice nurses compared with experts on the same ultrasound system, five blinded cardiologist reviewers · 240 clinically indicated echocardiography patients aged at least 22; 120 France and 120 US
exact submission · Tested version: HeartFocus v1.1.1 with Clarius · n=240 · 2 sites · Sponsor or vendor study
K242807
Eight nurses acquired ten views; four primary endpoints assessed examination suitability for visual LV size/function, RV size and nontrivial effusion evaluation. Secondary quality outcomes were descriptive and varied by view; not an autonomous diagnosis study.
Manufacturer standalone evaluation of view classification, guidance cues and recording, with expert annotations · 290 patients and 361,104 images in the test pool, with feature-specific subsets and additional retrospective evaluation of trial data
exact submission · Tested version: HeartFocus v1.1.1 · n=290 · Sponsor or vendor study
K242807
The 290-patient algorithm pool and 240-patient clinical study are distinct denominators, not a single combined cohort.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
The current HeartFocus family pricing page displays $695 per license/year/probe or $1,800 per license/three years/probe for up to five licenses, with unlimited users; enterprise six-plus licenses require a quote.
Public source Product family Checked 2026-09-05
Current family offer, not an exact v1.1.1/Clarius quote. The page shows a dollar sign but no ISO currency; no normalized price observation is emitted. Hardware, tax and local contract inclusions require confirmation.
Needs research Exact FDA submission Checked 2026-09-05
No applicable CMS policy content reviewed. Acquisition software pricing does not establish reimbursement for the software or the underlying echo service.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: FDA-local data flow is documented, but FAQ/pricing security language does not supply a dated scoped attestation or a complete installed security-control assessment.
Verify reimbursement and coding relevance: No applicable CMS policy content reviewed. Acquisition software pricing does not establish reimbursement for the software or the underlying echo service.
Verify local validation and lifecycle monitoring: Editorial acceptance questions concern installed probe/OS/model compatibility, per-view failures, rescue scanning, saved-clip review and DICOM transfer; no vendor monitoring service is verified.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-05Last searched
21Fields reviewed
12Source classes checked
0Reviewed PubMed leads
1Reviewed trial leads
0Unreviewed FDA recall leads
Stored DESKi-sponsored PROSPECTIVE EVALUATION OF HEARTFOCUS metadata screened. Live registry page exposed only an application shell, so trial details and exact release linkage were not established; no registry result promoted. Clinical-study abstraction is sourced to the FDA summary only. Stored PubMed array empty. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor pricing, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require...
GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC
FDA product code POK identifies this device class as Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer. Assist users in characterizing lesions identified on...
FDA product code QIH identifies this device class as Automated Radiological Image Processing Software. To provide automated radiological image processing and analysis tools....
PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable...